DaVita
DVA
#1816
Rank
C$16.39 B
Marketcap
C$255.50
Share price
1.26%
Change (1 day)
44.39%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): C$17.41

According to DaVita's latest financial reports the company's current EPS (TTM) is C$17.79. In 2025 the company made an earnings per share (EPS) of C$14.43 a decrease over its 2024 EPS that were of C$15.72.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$17.4120.69%
2025C$14.43-8.25%
2024C$15.7244.94%
2023C$10.8527.26%
2022C$8.52-35.56%
2021C$13.2344.1%
2020C$9.1819.7%
2019C$7.67540.48%
2018C$1.20-76.07%
2017C$5.00-19.31%
2016C$6.20242.52%
2015C$1.81-62.87%
2014C$4.8713.43%
2013C$4.308.45%
2012C$3.96

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$35.39 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$17.35-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$37.23 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$3.02-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA